Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Neuraxis Inc

NRXS ✓ COMPLIANT ☆ Track — members

NYSE American · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Micro Cap Analyst: BUY

Last Close

$6.30

▲ +0.32%

Market Cap $79.11M · Vol 6.29K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$79.11M

Micro Cap

Div Yield

N/A

EPS Growth

+28.42%

YoY

RSI (14)

42.90

Momentum

Beta

N/A

vs Market

52W High

$9.28

32.11% below

52W Low

$2.27

177.53% above

Volume

6.29K

Avg 8.06K

P/B

14.24

Price-to-book

ROE

N/A

Return on equity

Free Float

77.15%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Neuraxis Inc (NRXS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does NRXS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-11.14%

-11.89%

-24.55%

+28.31%

YTD

+38.77%

+165.82%

+23.53%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$3.57M
Net Income	$-7,800,560.00
Revenue Growth (YoY)	+115.72%
Gross Margin	84.23%
Operating Margin	-219.37%
Net Profit Margin	-218.55%
ROE	N/A
ROA · ROIC	-139.77% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	11.55
P/B	14.24
P/FCF	N/A
EPS Growth	+28.42%
Outstanding Shares	12.56M

Technical Indicators

50-Day SMA	$6.84
200-Day SMA	$5.69
RSI (14)	42.90
Beta	N/A
52-Week High	$9.28
52-Week Low	$2.27

Volume Today	6.29K
Avg Daily Volume (30D)	8.06K
Relative Volume	0.78x
Volatility (10D)	63.11
Volatility (30D)	51.38
Free Float	77.15%

Analyst Consensus

BUY

Current Price $6.30

Mean Target $11.00

52W Low$2.27 52W High$9.28

Current

Target

$2.27 $9.28

Current Analyst target

+74.60% upside potential · 2 analysts

Identifiers

ExchangeNYSE American

FIGIBBG01C9N1368

ISINUS64134X2018

CountryUnited States of America

Sub-IndustryMedical Equipment

Earnings DateNov 11, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

PEN Penumbra Inc +0.08% GETI B.ST Getinge publ AB +0.08% 7747.T Asahi Intecc Co Ltd -0.97% MMED MiniMed Group Inc +0.65% 688617.SS APT Medical Inc +0.14%

Company Profile

Neuraxis, Inc. is a medical technology company. The Company is focused on developing neuromodulation therapies for chronic and debilitating conditions in gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. Its IB-Stim, is a Percutaneous Electrical Nerve Field Stimulation (PENFS) technology intended to be used in patients eight years and older with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. Its second product, RED (Rectal Expulsion Device), is indicated to evaluate the neuromuscular function of a patient’s ability to expel its contents from the rectum and as a qualitative test for rectal hypersensitivity. RED (K242304, 2024) helps identify patients with rectal hypersensitivity who experience a desire or urge to defecate at lower volumes of distension.